» Articles » PMID: 8608881

Helicobacter Pylori Augments the PH-increasing Effect of Omeprazole in Patients with Duodenal Ulcer

Overview
Specialty Gastroenterology
Date 1996 Mar 1
PMID 8608881
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Omeprazole is less effective in healthy subjects than in patients with duodenal ulcers. The aim of this study was to determine whether Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcers.

Methods: In 16 patients with duodenal ulcers, baseline intragastric acidity was measured before and 4-6 weeks after the cure of H. pylori infection. In 17 patients with duodenal ulcers, 24-hour pH metry was performed during treatment with 20 mg omeprazole once daily before as well as after eradication of H. pylori. Intragastric acidity was measured using a glass electrode placed 5 cm below the cardia. H. pylori infection was assessed by [13C] urea breath test, culture, histology, and rapid urease test.

Results: H. pylori eradication resulted in marked decrease of the pH-increasing effect of omeprazole (24-hour median gastric pH, 5.5 vs. 3.0; P<0.002) that was most pronounced during nighttime (median gastric pH, 6.4 vs. 2.1; P=0.001). On the other hand, baseline intragastric pH remained unchanged after eradication (median gastric pH, 1.0 vs. 1.1; P=0.5).

Conclusions: In patients with duodenal ulcers treated with omeprazole, intragastric pH depends significantly on the presence or absence of H. pylori, whereas baseline pH remained unchanged after H. pylori eradication.

Citing Articles

Association Between Acid-Suppressive Agents' Use and Risk of Hepatocellular Carcinoma.

Lin H, Hsu H, Lin H, Uang Y, Ho Y, Wang L Dose Response. 2022; 18(2):1559325820907530.

PMID: 35185412 PMC: 8851131. DOI: 10.1177/1559325820907530.


Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical Trial.

Shu X, Zhu Z, Fu Y, Zhang Z, Wang J, Li X Front Med (Lausanne). 2021; 8:690995.

PMID: 34336894 PMC: 8317206. DOI: 10.3389/fmed.2021.690995.


Effect of acid-reducing agents on clinical relapse in ulcerative colitis with pH-dependent-released 5-aminosalicylic acid: a multicenter retrospective study in Japan.

Shimodaira Y, Onochi K, Watanabe K, Takahashi S, Fukuda S, Watanabe N Intest Res. 2020; 19(2):225-231.

PMID: 32806877 PMC: 8100376. DOI: 10.5217/ir.2020.00023.


And Duodenal Ulcer: Systematic Review Of Controversies In Causation.

Ahmed S, Belayneh Y Clin Exp Gastroenterol. 2019; 12:441-447.

PMID: 31819586 PMC: 6873956. DOI: 10.2147/CEG.S228203.


Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.

Mohn E, Kern H, Saltzman E, Mitmesser S, McKay D Pharmaceutics. 2018; 10(1).

PMID: 29558445 PMC: 5874849. DOI: 10.3390/pharmaceutics10010036.